2. Integrating Research into Outbreak Response: Use of Investigational Ebola Vaccines and Therapeutics During Outbreaks in the Democratic Republic of Congo
Session: Symposium: Late Breaker Infectious Disease Updates
Wednesday, October 3, 2018: 1:55 PM
Room: S 305-314
Elizabeth Higgs, MD, Division of Clinical Research, National Institutes of Health, Rockville, MD

Dr. Elizabeth Higgs, MD, MIA, DTM&H is a global health science advisor and clinical scientist for the National Institute of Allergy and Infectious Diseases’, Division of Clinical Research (DCR) at the National Institutes of Health, within the USG’s Department of Health and Human Services. Dr. Higgs provides expertise for DCR’s emergency response research activities including the establishment of an accelerated clinical research response for the USG in West Africa during the 2014-2016 Ebola, the 2018 Nipah outbreak in Kerala, India, and the 2018 DRC Ebola outbreaks. She serves as an investigator on a variety of protocols and is a DCR liaison and SME for emergency response research to World Health Organization, other multilaterals, and collaborations with other USG agencies. She was formerly seconded by NIH to USAID as Science Advisor for Research and Innovation to the USG Global Heath Initiative and to the USAID Global Health Bureau where she focused on science for development issues including USG Global Health Evidence Summits, Evidence Evaluation Frameworks for Global Health decision making, and smart linkages between USG development and science agencies, such as Partnerships for Enhanced Engagement in Research’s Implementation Science for Child Survival. Dr. Higgs facilitated development of a multilateral effort to establish social sciences norms in global health and served as an SME for the WHO Good Participatory Practices for Epidemic Pathogens Guidelines to enhance social mobilization, communication, and community engagement in outbreak response research. A career focus includes the development of independent sustainable research capacity in low and middle-income countries. She recently served on the World Bank International Vaccine Task Force responsible for the Money and Microbes: Clinical Research Preparedness for Prevention of Epidemics intended to establish clinical research capacity for preparedness and epidemic response. Research interests have focused broadly on: emerging infectious diseases, influenza therapeutics, HIV, tropical diseases, nutrition, Ebola, Nipah, and emergency research response. She is trained in internal medicine and infectious diseases. She holds doctorate in medicine, a master’s degree in International Affairs, an interdisciplinary bachelor’s degree in bioethics, and a Diploma in Tropical Medicine and Hygiene.


Disclosures:

E. Higgs, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.